News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Gaya Ratnaswamy

Advertisement

Gaya Ratnaswamy is director, Analytical and Formulation Development at Agensys, Inc., Santa Monica, CA.

Articles by Gaya Ratnaswamy

Characterization and Formulation Screening of mAb and ADCs by High-Throughput DLS

ByJihea Park,Aileen La,Ananda Seneviratne,Gaya Ratnaswamy
October 2nd 2015
Advertisement

Latest Updated Articles

  • Characterization and Formulation Screening of mAb and ADCs by  High-Throughput DLS
    Characterization and Formulation Screening of mAb and ADCs by High-Throughput DLS

    Published: October 2nd 2015 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge

2

Application of alternative electron-based fragmentation for identification of drug metabolites and quantification of complex peptide therapeutics

3

Confident characterization and identification of glucuronide metabolites using diagnostic fragments from electron activated dissociation (EAD)

4

Confident identification of phase 1 metabolites using electron activated dissociation (EAD)

5

Targeted high resolution metabolite screening workflows

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us